Randomization And Trial Supply Management Report

By www.reliableresearchiq.com

Report Details

Report Name

Global Randomization And Trial Supply Management Market Growth (Status And Outlook) 2024-2030 Story

Pages

151

Price

$ 3660

Features

Randomization And Trial Supply Management Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              "Calyx"|||"Almac"|||"ICON plc"|||"Trialogics"|||"IBM"|||"Medpace CRO"|||"Endpoint Clinical"|||"Everest"|||"Eclipse"|||"PPD Inc"|||"Statistics & Data Corporation"|||"Cenduit"|||"Clario"|||"Bracket"|||"Criterium"|||"DSG"|||"Suvoda"|||"Oracle"|||"Parexel"|||"S-Clinica"|||"Veeva Systems"|||"Yprime"|||"Rho|||Inc"|||"Medidata"|||"Axiom Real-Time Metrics"|||"Crucial Data Solutions"|||"Clinion"|||"Venn Life Sciences"|||"Cloudbyz"|||"Datatrak"            

Countries Covered

              "United States"|||"Canada"|||"Mexico"|||"Brazil"|||"China"|||"Japan"|||"Korea"|||"Southeast Asia"|||"India"|||"Australia"|||"Germany"|||"France"|||"UK"|||"Italy"|||"Russia"|||"Egypt"|||"South Africa"|||"Israel"|||"Turkey"|||"GCC Countries"            

Regions Covered

              Global            

Prices

Single User License:

$ 3660

Multi User License:

$ 5490

Enterprise/Corporate User License:

$ 7320